Fat-soluble vitamin compounds for targeting drug delivery and enhancing siRNA activity
Here described are compounds of formula I: wherein R1 and R2 is independently selected from a group consisting of C10 to C18 alkyl, C12 to C18 alkenyl, and oleoyl group; wherein R3 and R4 are independently selected from a group consisting of H, C1 to C6 alkyl, and C1 to C6 alkanol; wherein X is sele...
Saved in:
Main Authors | , , , , , , , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
01.04.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Here described are compounds of formula I: wherein R1 and R2 is independently selected from a group consisting of C10 to C18 alkyl, C12 to C18 alkenyl, and oleoyl group; wherein R3 and R4 are independently selected from a group consisting of H, C1 to C6 alkyl, and C1 to C6 alkanol; wherein X is selected from a group consisting of -CH2-, -S-, and -O-; wherein Y is selected from -(CH2)n, -S(CH2)n, -O(CH2)n-, thiophene, -SO2(CH2)n-, and ester, wherein n = 1-4; and wherein Z is a counterion; and compounds consisting of the structure (targeting molecule)n-linker-(targeting molecule)n, wherein the targeting molecule is a retinoid or a fat soluble vitamin having a specific receptor on the target cell; wherein n=0, 1, 2 or 3; and wherein the linker comprises a polyethylene glycol (PEG) or PEG-like molecule, as well as compositions and pharmaceutical formulations including one or both of these compounds which are useful for the delivery of therapeutic agents; and methods of using these compositions and pharmaceutical |
---|---|
Bibliography: | Application Number: TW20121120844 |